ITGA10 is believed to drive osteosarcoma proliferation and chemotherapy resistance by mediating the PI3K/AKT pathway and is also considered a potential diagnostic and prognostic marker in THCA (47, 48). This evidence concerns the gene ITGA10 and osteosarcoma.